Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_001379110.1(SLC9A6):c.-57+21del

CA16621203

422694 (ClinVar)

Gene: SLC9A6
Condition: Christianson syndrome
Inheritance Mode: X-linked inheritance
Link to MONDO
UUID: 5cad9377-3823-4bfb-92c5-9fd7ad040f22
Approved on: 2024-02-23
Published on: 2024-03-31

HGVS expressions

NM_001379110.1:c.-57+21del
NM_001379110.1(SLC9A6):c.-57+21del
NC_000023.11:g.135985498del
CM000685.2:g.135985498del
NC_000023.10:g.135067657del
CM000685.1:g.135067657del
NC_000023.9:g.134895323del
NG_017160.1:g.5072del
ENST00000370695.8:c.-5del
ENST00000370701.6:c.-57+21del
ENST00000630721.3:c.-57+21del
ENST00000636092.1:c.-56-105del
ENST00000636347.1:c.-35-126del
ENST00000637195.1:c.-35-126del
ENST00000637234.1:c.-56-105del
ENST00000637581.1:c.-56-105del
ENST00000678163.1:c.-5del
ENST00000370695.6:c.-5del
ENST00000370698.7:c.-5del
ENST00000370701.5:c.-57+21del
ENST00000627534.2:c.-57+26del
NM_001042537.1:c.-5del
NM_001177651.1:c.-57+21del
NM_006359.2:c.-5del
NM_001330652.1:c.-57+26del
NM_001177651.2:c.-57+21del
NM_001330652.2:c.-57+26del
NM_006359.3:c.-5del
NM_001042537.2:c.-5del
NM_001400909.1:c.-35-126del
NM_001400910.1:c.-56-105del
NM_001400911.1:c.-56-105del
NM_001400912.1:c.-57+26del
NM_001400913.1:c.-57+21del
More

Benign

Met criteria codes 3
BP4 BS2 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for SLC9A6 Version 3.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The allele frequency of the c.-5del variant in SLC9A6 (NM_006359.2) is 0.02% in European (non-Finnish) sub population in gnomAD v2, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Splice prediction analysis, using multiple computational tools does not suggest an impact to splicing (BP4). The c.-5del variant is observed in the hemizygous state in at least 2 unaffected individuals (internal database - GeneDx) (BS2). In sumarry, the c.-5del variant in SLC9A6 is classified as benign based on the ACMG/AMP criteria (BS1, BP4, BS2).
Met criteria codes
BP4
Splice prediction analysis, using multiple computational tools does not suggest an impact to splicing (BP4).
BS2
The c.-5del variant is observed in the hemizygous state in at least 2 unaffected individuals (internal database - GeneDx) (BS2).
BS1
The allele frequency of the c.-5del variant in SLC9A6 (NM_006359.2) is 0.02% in European (non-Finnish) sub population in gnomAD v2, which is high enough to meet the BS1 criteria based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.